Combination drug therapies for AD: progress is slow, but we must keep trying
Farlow, M.R.
Geriatrics 60(6): 13-14
2005
ISSN/ISBN: 0016-867X PMID: 15948660 Document Number: 584765
Document emailed within 1 workday
Related Documents
Katzenstein, D. 1997: Combination therapies for HIV infection and genomic drug resistance Lancet 350(9083): 970-971Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454
Wang, L.H. 1993: Progress in interventional therapies in cardiology Zhonghua Xin Xue Guan Bing Za Zhi 21(6): 362-364
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Wadhams, N. 2010: Progress in Rwanda's drive to slow population growth Lancet 376(9735): 81-82
Shetty, P. 2014: Slow progress in ending female genital mutilation Bulletin of the World Health Organization 92(1): 6-7
Calgüneri, M.; Cobankara, V.; Oztürk, M.A.; Ertenli, I.; Kiraz, S.; Apraş, S. 2004: Combination therapies in spondyloarthropathies Kobe Journal of Medical Sciences 50(1-2): 31-37
Mudur, G. 2004: Audit report criticises India's slow progress on AIDS Bmj 329(7460): 252
Gennigens, C.; Sautois, B.; Rorive, A.; Fillet, G.; Jerusalem, G. 2007: Current therapeutic progress in oncology: the development of targeted therapies Revue Medicale de Liege 62(5-6): 391-398
Takeshita, A.; Ohno, R. 2000: New combination therapies in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(3): 388-394
King, L.S. 1983: Medicine in the USA: historical vignettes. VII. the painfully slow progress in medical education JAMA 249(2): 270-274
Zarbin, M.A. 2014: The First International Optogenetic Therapies for Vision Symposium: Translational Medicine in Progress JAMA Ophthalmology 132(9): 1043-1044
Yang, M.; Xu, H. 2009: Application potentials and research progress of nanoparticle technologies in immune therapies Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26(1): 187-190
Zarbin, M.A. 2014: The First International Optogenetic Therapies for Vision Symposium: Translational Medicine in Progress JAMA Ophthalmology 132(9): 1043-1044
Tawbi, H.; Tawbi, H. 2015: Combination therapies for treating metastatic melanoma Clinical Advances in Hematology and Oncology: H&o 13(4): 211-214
Lencioni, R.; Cioni, D.; Donati, F.; Bartolozzi, C. 2001: Combination of interventional therapies in hepatocellular carcinoma Hepato-Gastroenterology 48(37): 8-14
Vleggaar, F.P.; Van Ooteghem, N.A.; Van Buuren, H.R.; Van Berge Henegouwen, G.P. 2000: Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders Scandinavian Journal of Gastroenterology. Suppl 232: 86-92
Lehmann, G.; Reiniger, G.; Wolf, H.; Beyerle, A.; Rudolph, W. 1990: Effectiveness of various combination therapies in patients with coronary heart disease Herz 15(6): 399-409
Cotton, P. 1991: Combination therapies may speed healing, reduce rebleeding of esophageal varices JAMA 266(2): 187-188
Burns, J. 2011: Insurers move toward more equitable care for LGBT population. Discrimination persists in many areas, but slow progress is being made Managed Care 20(11): 39-42; 49